Drug Manufacturers - Specialty & Generic (industry)

Compare top 5 →
OverviewAI BriefPerformanceCompositionScoresCompaniesNews
Q-Score59
Market Cap$361.2B
Aggregate P/E79.99
Dividend Yield1.22%
1Y Return+42.4%
Advancing (1M)35.80%
AI summary

Returns

+42.4%over the year
Cap-weightedMedianUp
1M+9.0%-7.1%36%
3M+10.7%-8.4%41%
YTD+23.2%-12.9%41%
1Y+42.4%-21.5%38%

Led by the largest companies: the median company returned -21.5%.

Returns by horizon and breadth

This month's movers

Leaders
  • LQDALiquidia Corporation+101.6%
  • XERSXeris Biopharma Holdings, Inc.+51.0%
  • PCRXPacira BioSciences, Inc.+44.4%
  • BHCBausch Health Companies Inc.+40.7%
  • KNSAKiniksa Pharmaceuticals International, plc+25.1%
Laggards
  • HIMSHims & Hers Health, Inc.-38.1%
  • SUPNSupernus, Inc.-33.6%
  • AQSTAquestive Therapeutics, Inc.-16.5%
  • ALVOAlvotech-12.8%
  • TKNOAlpha Teknova, Inc.-12.4%
Every horizon's leaders and laggards

News sentiment

Open News

Largest companies

The map and every share

Size

Revenue$162.9B
Earnings$4.5B
Companies81
Concentration (HHI)0.14
Size and financials

Q-Score profile

59/ 100
Every score and metric

Valuation

Aggregate P/E79.99
Aggregate P/S2.22
Dividend yield1.22%
Earnings yield1.25%
Net margin2.77%
The valuation map

Revenue exposure

Outside the US45.98%
From Greater China—
Largest customer (avg.)—
Revenue covered69.09%
Size and financials